The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

被引：0
|
作者：
Heerspink, J. L. [1 ]
Wheeler, D. C. [2 ]
Vart, P. [1 ]
Jongs, N. [1 ]
Hou, F. F. [3 ]
Langkilde, A. M. [4 ]
Correa-Rotter, R. [5 ]
Rossing, P. [6 ]
Sjostrom, C. D. [4 ]
Toto, R. D. [7 ]
Chertow, G. M. [8 ]
Stefansson, B. V. [4 ]
McMurray, J. J. V. [9 ]
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
[2] UCL, London, England
[3] Southern Med Univ, Nanfang Hosp, Affiliated Hosp, Guangzhou, Peoples R China
[4] AstraZeneca, Gothenburg, Sweden
[5] Natl Inst Med Sci & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[6] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[7] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[8] Sch Med, Stanford, CA USA
[9] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2913 / 2913
页数：1
相关论文
共 50 条
  • [41] Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
    Chertow, Glenn M.
    Vart, Priya
    Jongs, Niels
    Toto, Robert D.
    Gorriz, Jose Luis
    Hou, Fan Fan
    McMurray, John J. V.
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, C. David
    Stefansson, Bergur V.
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (09): : 2352 - 2361
  • [42] THE EFFECTS OF TOLVAPTON ON SEVERE CHRONIC KIDNEY DISEASE PATIENTS WITH CONGESTIVE HEART FAILURE
    Koibuchi, Kiyoto
    Aoki, Toshiyuki
    Miyagi, Moriatsu
    Sakai, Ken
    Aikawa, Atsushi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 166 - 166
  • [43] QUANTIFYING THE RELATIONSHIP BETWEEN HYPERKALAEMIA AND OUTCOMES IN PATIENTS WITH HEART FAILURE OR CHRONIC KIDNEY DISEASE
    Bennett, H.
    Ayoubkhani, D.
    Evans, M.
    McEwan, M.
    Qin, L.
    Grandy, S.
    Palaka, E.
    VALUE IN HEALTH, 2017, 20 (09) : A682 - A682
  • [44] CLINICAL OUTCOMES OF HEART FAILURE PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE TAKING ERYTHROPOIETIN
    Jackevicius, Cynthia
    Warner, Alberta
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [45] Outcomes and Disparities of Asian Patients With Severe Chronic Kidney Disease Admitted for Heart Failure
    Tan, Samuel
    Siu, Wenchy
    Kumar, Shasawat
    Adinugraha, Paulus
    CIRCULATION, 2023, 148
  • [46] Clinical Outcomes of Erythropoietin Use in Heart Failure Patients With Anemia of Chronic Kidney Disease
    Jackevicius, Cynthia A.
    Fan, Cindy Shutieng
    Warner, Alberta
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (05) : 327 - 333
  • [47] Dapagliflozin versus empagliflozin in patients with chronic kidney disease
    Alnsasra, Hilmi
    Tsaban, Gal
    Solomon, Adam
    Khalil, Fouad
    Aboalhasan, Enis
    Azab, Abed N.
    Azuri, Joseph
    Hammerman, Ariel
    Arbel, Ronen
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [48] Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter
    Levin, A
    Djurdjev, O
    Barrett, B
    Burgess, E
    Carlisle, E
    Ethier, J
    Jindal, K
    Mendelssohn, D
    Tobe, S
    Singer, J
    Thompson, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) : 1398 - 1407
  • [49] Dapagliflozin for rheumatic musculoskeletal disease in patients with chronic kidney disease
    Hanaoka, Hironari
    Kikuchi, Jun
    Hiramoto, Kazuoto
    Akiyama, Mitsuhiro
    Saito, Shutaro
    Kondo, Yasushi
    Azegami, Tatsuhiko
    Kaneko, Yuko
    MODERN RHEUMATOLOGY, 2024,
  • [50] Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease
    Neuen, Brendon L.
    Ohkuma, Toshiaki
    Neal, Bruce
    Matthews, David R.
    Mahaffey, Kenneth W.
    Fulcher, Greg
    Desai, Mehul
    Li, Qiang
    Deng, Hsiaowei
    Rosenthal, Norm
    Jardine, Meg
    Bakris, George
    Perkovic, Vlado
    DIABETES, 2018, 67
12345